IFNA1 and neoplasm: During the last decade, the proponent’s research unit has developed and optimized a procedure to generate donor-derived CTLs directed against pediatric acute LB, through the stimulation of peripheral blood mononuclear cells (PBMC) with IFN-dendritic cells (IFN-DC) pulsed with apoptotic LB as source of tumor antigens.